Cited by 1,163Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismParaoxonase enzyme and polymorphisms

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Open access

Stampfer, Meir J., Sacks, Frank M., Salvini, Simonetta, Willett, Walter C., Hennekens, Charles H.·1991·New England Journal of Medicine

DOI 10.1056/nejm199108083250601

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The independent contributions of subfractions of high-density lipoprotein (HDL) cholesterol (HDL2 and HDL3) and apolipoproteins in predicting the risk of myocardial infarction are unclear. Prospective data are sparse, but HDL2 is widely believed to be a more important predictor than HDL3. METHODS: Blood samples were collected at base line from 14,916 men (ages, 40 to 84 years) who were participants in the Physicians' Health Study. After five years of follow-up, plasma samples from 246 men with new myocardial infarction (case subjects) were analyzed together with specimens from 246 men matched to them for age and smoking status who had not had a myocardial infarction. RESULTS: The levels of total cholesterol and apolipoprotein B-100 were significantly associated with an increased risk of myocardial infarction (data on levels of low-density lipoprotein cholesterol were unavailable). Both HDL cholesterol and HDL2 levels were associated with a substantially decreased risk of myocardial infarction, but the HDL3 level was the strongest predictor; the relative risk was 0.3 (95 percent confidence interval, 0.2 to 0.6) for those in the fifth of the group with the highest HDL3 levels, as compared with the fifth with the lowest levels. The benefit of a higher HDL cholesterol level was most pronounced among those with lower total cholesterol levels. Levels of apolipoprotein A-I and apolipoprotein A-II were also associated with decreased risk. However, the levels of HDL subfractions and apolipoproteins did not add significantly to the value of a multivariate model that included the ratio of total to HDL cholesterol in predicting myocardial infarction, whereas that ratio remained a significant independent predictor of risk. After adjustment for other risk factors, a change of one unit in the ratio of total to HDL cholesterol was associated with a 53 percent change in risk (95 percent confidence interval, 26 percent to 85 percent). CONCLUSIONS: This study underscores the importance of HDL cholesterol in predicting the risk of myocardial infarction and demonstrates protective effects of both the HDL3 and HDL2 subfractions of HDL cholesterol. We found little or no predictive value for the levels of apolipoproteins A-I, A-II, and B or HDL subfractions after conventional risk factors and the ratio of total to HDL cholesterol were considered.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199108083250601

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

From the New York Times Magazine
Minsky, & Hyman, P. (1979) · Cited by 6,899
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
THE TROMSØHEART-STUDY
Miller, N. E., Thelle, D. S., Førde, O. H., & Mjøs, O. D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92274-7 · Cited by 1,206
Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure
Gidez, L. I., Miller, G. J., Burstein, M., Slagle, S., & Eder, H. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38059-7 · Cited by 757
Ischemic Heart Disease, Atherosclerosis, and Longevity
Gofman, J. W., Young, W., & Tandy, R. K. (1966) · Circulation · doi:10.1161/01.cir.34.4.679 · Cited by 587
Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery Disease
Maciejko, J. J., Holmes, D. R., Kottke, B. A., Zinsmeister, A. R., Dinh, D. M., & Mao, S. J. T. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090701 · Cited by 537
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel
Goodman, D. S., Hulley, S. B., Clark, L. T., Davis, C. E., Fuster, V., LaRosa, J. C., Oberman, A., Schaefer, E. J., Steinberg, D., Brown, W. V., et al. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.1.36 · Cited by 529
ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS?
Avogaro, P., Bon, G. B., Avogaro, P., Cazzolato, G., & Quinci, G. B. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91375-8 · Cited by 523

Show all 56 references

Research works printed but not linked: 10

Enger, 1979, Artery, 5, 170
Bennett, 1988, New York Times Magazine, 55
Jones PH, Gotto AM Jr. Assessment of lipid abnormalities. In: Hurst JW, Schlant RC, Rachley CE, Sonnenblick EH, Wenger NK, eds. The heart: arteries and veins. 7th ed. New York: McGraw-Hill, 1990:378–84.
10.1001/archinte.150.8.1645 · DOI
Musliner, 1988, Clin Chem, 34, B78
Hennekens, 1987, Circulation, 76, IV-501
Kempen, 1987, J Lab Clin Med, 109, 19
Avogaro P, Cazzolato G, Bittolo Bon G, Rorai E, Pontoglio E. Lipoprotein derangements in human atherosclerosis. In: Noseda G, Fragiacomo C, Fumagalli R, Paoletti R, eds. Lipoproteins and coronary atherosclerosis. Amsterdam: Elsevier, 1982:123–42.
Kladetzky, 1980, Artery, 7, 191
Desager JP, Rousseau M, Riesen WF, Harvengt C. Limitations of the predictive value for coronary vascular disease of plasma lipids and apoproteins AI, AII, B levels as measured before coronarography in 317 patients. In: de Gennes JL, Polonovski J, Paoletti R, eds. Latent dyslipoproteinemias and atherosclerosis. New York: Raven Press, 1984:165–74.

Sorted by citations

Items 101–200 of 999

Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study.
Schaefer, E. J., Lamon‐Fava, S., Ordovás, J. M., Cohn, S. D., Schaefer, M. M., Castelli, W. P., & Wilson, P. W. F. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39181-1 · Cited by 200
Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk.
Pacifico, L., Nobili, V., Anania, C., Verdecchia, P., & Chiesa, C. (2011) · Europe PMC (PubMed Central) · doi:10.3748/wjg.v17.i26.3082 · Cited by 201
Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study
van Dam, M., de Groot, E., Clee, S. M., Hovingh, G. K., Roelants, R. J., Brooks-Wilson, A., Zwinderman, A. H., Smit, A. J., Smelt, A. H. M., Groen, A. K., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07277-x · Cited by 196
Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux.
Banka, C. L., Yuan, T., de Beer, M. C., Kindy, M. S., Curtiss, L. K., & de Beer, F. C. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39863-1 · Cited by 197
Trans fatty acids: are the effects only marginal?
Willett, W. C., & Ascherio, A. (1994) · American Journal of Public Health · doi:10.2105/ajph.84.5.722 · Cited by 194
Self-citation
Distribution of ApoA-I–Containing HDL Subpopulations in Patients With Coronary Heart Disease
Asztalos, B. F., Roheim, P. S., Milani, R. V., LeFevre, M. L., McNamara, J. R., Horvath, K. V., & Schaefer, E. J. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.12.2670 · Cited by 193
Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed Rabbits
Miyazaki, A., Sakuma, S., Morikawa, W., Takiue, T., Miake, F., Terano, T., Sakai, M., Hakamata, H., Sakamoto, Y.-I., Naito, M., et al. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1882 · Cited by 190
Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice.
Li, H., Reddick, R. L., & Maeda, N. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.12.1814 · Cited by 189
Laboratory Assessment of HDL Heterogeneity and Function
Movva, R., & Rader, D. J. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.101923 · Cited by 190
Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men
Sigurðsson, G., Baldursdóttir, Á., Sigvaldason, H., Agnarsson, U., Þorgeirsson, G., & Sigfússon, N. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91215-p · Cited by 187
Trans Fats in America: A Review of Their Use, Consumption, Health Implications, and Regulation
Remig, V. M., Franklin, B., Margolis, S., Kostas, G., Nece, T., & Street, J. C. (2010) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2009.12.024 · Cited by 189
Depressed serum high density lipoprotein cholesterol levels in veterans with spinal cord injury
Bauman, W. A., Spungen, A. M., Zhong, Y.-G., Rothstein, J. L., Petry, C. D., & Gordon, S. K. (1992) · Spinal Cord · doi:10.1038/sc.1992.136 · Cited by 182
Value of HDL Cholesterol, Apolipoprotein A-I, Lipoprotein A-I, and Lipoprotein A-I/A-II in Prediction of Coronary Heart Disease
Luc, G., Bard, J., Ferrières, J., Evans, A., Amouyel, P., Arveiler, D., Fruchart, J., & Ducimetière, P. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000022850.59845.e0 · Cited by 179
Insulin-like Growth Factors and Prostate Cancer
Pollak, M., Beamer, W., & Zhang, J. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1006154108619 · Cited by 179
Atherosclerotic Disease in Marked Hyperalphalipoproteinemia
Hirano, K., Yamashita, S., Kuga, Y., Sakai, N., Nozaki, S., Kihara, S., Arai, T., Yanagi, K., Takami, S., Menju, M., et al. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1849 · Cited by 175
HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the lipoprotein investigators collaborative
Martin, S. S., Khokhar, A. A., May, H. T., Kulkarni, K. R., Blaha, M. J., Joshi, P. H., Toth, P. P., Muhlestein, J. B., Anderson, J. L., Knight, S., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu264 · Cited by 178
Dietary conjugated linoleic acids promote fatty streak formation in the C57BL/6 mouse atherosclerosis model
Munday, J. S., Thompson, K. G., & James, K. A. C. (1999) · British Journal Of Nutrition · doi:10.1017/s0007114599000458 · Cited by 175
ABCA1 and ABCG1 as potential therapeutic targets for the prevention of atherosclerosis
Matsuo, M. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.11.005 · Cited by 182
Lipoprotein Subclasses in the Monitored Atherosclerosis Regression Study (MARS)
Mack, W. J., Krauss, R. M., & Hodis, H. N. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.5.697 · Cited by 173
High-Density Lipoprotein Deficiency and Dyslipoproteinemia Associated With Venous Thrombosis in Men
Deguchi, H., Pecheniuk, N. M., Elias, D. J., Averell, P. M., & Griffin, J. H. (2005) · Circulation · doi:10.1161/circulationaha.104.521344 · Cited by 176
Associations of HDL 2 and HDL 3 Subfractions With Ischemic Heart Disease in Men
Lamarche, B., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J., & Després, J. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.6.1098 · Cited by 167
Toward the quiescent coronary plaque
MacIsaac, A. I., Thomas, J. A. M. D., & Topol, E. J. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90442-4 · Cited by 166
Extended-Release Niacin vs Gemfibrozil for the Treatment of Low Levels of High-Density Lipoprotein Cholesterol
Guyton, J. R. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.8.1177 · Cited by 165
Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Obesity
Brehm, A., Pfeiler, G., Pacini, G., Vierhapper, H., & Roden, M. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.037556 · Cited by 169
Role of the Apolipoprotein B–Apolipoprotein A-I Ratio in Cardiovascular Risk Assessment: A Case–Control Analysis in EPIC-Norfolk
van der Steeg, W. A., Boekholdt, S. M., Stein, E. A., El-Harchaoui, K., Stroes, E. S. G., Sandhu, M. S., Wareham, N. J., Jukema, J. W., Luben, R., Zwinderman, A. H., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-9-200705010-00007 · Cited by 165
Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV.
Cohen, R. D., Castellani, L. W., Qiao, J. H., Lenten, B. J. V., Lusis, A. J., & Reue, K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119358 · Cited by 165
A Macadamia Nut-Rich Diet Reduces Total and LDL-Cholesterol in Mildly Hypercholesterolemic Men and Women
Griel, A. E., Cao, Y., Bagshaw, D., Cifelli, A. M., Holub, B. J., & Kris‐Etherton, P. M. (2008) · Journal of Nutrition · doi:10.1093/jn/138.4.761 · Cited by 165
Alterations of serum lipid levels and their biological relevances during and after pregnancy
Chiang, A.-N., Man-Li, Y., Jeng-Hsiu, H., Chou, P., Shin-Kuo, S., & Heung-Tat, N. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00230-4 · Cited by 163
Malignant coronary artery disease in young asian indians: Thoughts on pathogenesis, prevention, and therapy
Enas, E. A., & Mehta, J. L. (1995) · Clinical Cardiology · doi:10.1002/clc.4960180305 · Cited by 162
Cross-Sectional Study of Soluble Intercellular Adhesion Molecule-1 and Cardiovascular Risk Factors in Apparently Healthy Men
Rohde, L. E. P., Hennekens, C. H., & Ridker, P. M. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.7.1595 · Cited by 159
Self-citation
Cholesterol and the Risk of Ischemic Stroke
Bowman, T. S., Sesso, H. D., Ma, J., Kurth, T., Kase, C. S., Stampfer, M. J., & Gaziano, J. M. (2003) · Stroke · doi:10.1161/01.str.0000102171.91292.dc · Cited by 157
Self-citation
Longitudinal study of alcohol consumption and HDL concentrations: a community-based study
Huang, S., Li, J., Shearer, G. C., Lichtenstein, A. H., Zheng, X., Wu, Y., Jin, C., Wu, S., & Gao, X. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.144832 · Cited by 156
Apolipoprotein B and AI distributions in the United States, 1988–1991: results of the National Health and Nutrition Examination Survey III (NHANES III)
Bachorik, P. S., Lovejoy, K. L., Carroll, M. D., & Johnson, C. L. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.12.2364 · Cited by 156
A prospective study of fibrinogen and risk of myocardial infarction in the physicians’ health study
Ma, J., Hennekens, C. H., Ridker, P. M., & Stampfer, M. J. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00007-8 · Cited by 155
Self-citation
Prevalence of Uncomplicated Obesity in an Italian Obese Population
Iacobellis, G., Ribaudo, M. C., Zappaterreno, A., Iannucci, C. V., & Leonetti, F. (2005) · Obesity Research · doi:10.1038/oby.2005.130 · Cited by 151
Effect of training intensity on physical capacity, lipid profile and insulin sensitivity in early rehabilitation of spinal cord injured individuals
de Groot, P. C. E., Hjeltnes, N., Heijboer, A. C., Stal, W., & Birkeland, K. (2003) · Spinal Cord · doi:10.1038/sj.sc.3101534 · Cited by 149
Effect of Continuous Positive Airway Pressure Treatment on Serum Cardiovascular Risk Factors in Patients With Obstructive Sleep Apnea-Hypopnea Syndrome
Steiropoulos, P., Tsara, V., Nena, E., Fitili, C., Kataropoulou, M., Froudarakis, Μ. E., Christaki, P. I., & Bouros, D. E. (2007) · CHEST Journal · doi:10.1378/chest.07-0074 · Cited by 150
Long Term Effects of Ketogenic Diet in Obese Subjects with High Cholesterol Level
Dashti, H. M., Al-Zaid, N. S., Mathew, T. C., Al-Mousawi, M., Talib, H., Asfar, S., & Behbahani, A. I. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-9001-x · Cited by 148
Cholesteryl Ester Transfer Protein Taq I B2B2 Genotype Is Associated With Higher HDL Cholesterol Levels and Lower Risk of Coronary Heart Disease End Points in Men With HDL Deficiency
Brousseau, M. E., O’Connor, J. J., Ordovás, J. M., Collins, D. E., Otvos, J. D., Massov, T., McNamara, J. R., Bloomfield, H. E., Robins, S. J., & Schaefer, E. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000024566.57589.2e · Cited by 149
Low-density-lipoprotein subclasses and response to a low-fat diet in healthy men
Krauss, R., & Dreon, D. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.2.478s · Cited by 144
Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients
Morris, S. J., Wasko, M. C., Antohe, J. L., Sartorius, J. A., Kirchner, H. L., Dancea, S., & Bili, A. (2010) · Arthritis Care & Research · doi:10.1002/acr.20393 · Cited by 144
Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study
Hadaegh, F., Harati, H., Ghanbarian, A., & Azizi, F. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000216552.81882.ca · Cited by 144
Effects of hempseed and flaxseed oils on the profile of serum lipids, serum total and lipoprotein lipid concentrations and haemostatic factors
Schwab, U., Callaway, J. C., Erkkilä, A. T., Gynther, J., Uusitupa, M. I. J., & Järvinen, T. (2006) · European Journal of Nutrition · doi:10.1007/s00394-006-0621-z · Cited by 144
Cholesterol measures to identify and treat individuals at risk for coronary heart disease
Natarajan, S., Glick, H. A., Criqui, M. H., Horowitz, D., Lipsitz, S. R., & Kinosian, B. P. (2003) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(03)00092-8 · Cited by 142
Evaluation of Methods for the Measurement of Low-Density Lipoprotein Cholesterol
Bairaktari, E. T., Seferiadis, K. I., & Elisaf, M. (2005) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840501000106 · Cited by 142
Fibrates for secondary prevention of cardiovascular disease and stroke
Wang, D., Liu, B., Tao, W., Hao, Z., & Liu, M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009580.pub2 · Cited by 142
Apolipoprotein C‐III as a Potential Modulator of the Association Between HDL‐Cholesterol and Incident Coronary Heart Disease
Jensen, M. K., Rimm, E. B., Furtado, J. D., & Sacks, F. M. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.111.000232 · Cited by 142
Self-citation
Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study
Meisinger, C., Loewel, H., Wilfried, M. R. A. Z., & Köenig, W. (2004) · European Heart Journal · doi:10.1093/eurheartj/ehi003 · Cited by 142
Plasma apolipoprotein A1 as a biomarker for Parkinson disease
Qiang, J. K., Wong, Y. C., Siderowf, A. D., Hurtig, H. I., Xie, S. X., Lee, V. M. ‐., Trojanowski, J. Q., Yearout, D., Leverenz, J. B., Montine, T. J., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23872 · Cited by 142
Trans-fatty acid intake in relation to serum lipid concentrations in adult men
Troisi, R. J., Willett, W. C., & Weiss, S. T. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/56.6.1019 · Cited by 140
Self-citation
High-density lipoprotein subclasses and their relationship to cardiovascular disease
Superko, H. R., PENDYALA, L. K., Williams, P. T., Momary, K. M., King, S. B., & Garrett, B. C. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.03.001 · Cited by 142
Usefulness of Childhood Non–High Density Lipoprotein Cholesterol Levels Versus Other Lipoprotein Measures in Predicting Adult Subclinical Atherosclerosis: The Bogalusa Heart Study
Frontini, M., Srinivasan, S. R., Xu, J.-H., Tang, R., Bond, M. G., & Berenson, G. S. (2008) · PEDIATRICS · doi:10.1542/peds.2007-1472 · Cited by 136
Liver X Receptor Agonists as Potential Therapeutic Agents for Dyslipidemia and Atherosclerosis
Lund, E. G., Menke, J. G., & Sparrow, C. P. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000056743.42348.59 · Cited by 135
Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis.
Drexel, H., Amann, F. W., Beran, J., Rentsch, K., CANDINAS, R., Muntwyler, J., Luethy, A., Gasser, T., & Folláth, F. (1994) · Circulation · doi:10.1161/01.cir.90.5.2230 · Cited by 134
Daily Consumption of an Aqueous Green Tea Extract Supplement Does Not Impair Liver Function or Alter Cardiovascular Disease Risk Biomarkers in Healthy Men
Frank, J., George, T. W., Lodge, J. K., Rodriguez‐Mateos, A., Spencer, J. P. E., Minihane, A. M., & Rimbach, G. H. (2008) · Journal of Nutrition · doi:10.3945/jn.108.096412 · Cited by 133
Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease
Franceschini, G. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02146-4 · Cited by 131
Genetic Variation in ABCA1 Predicts Ischemic Heart Disease in the General Population
Frikke‐Schmidt, R., Nordestgaard, B. G., Jensen, G. B., Steffensen, R., & Tybjærg‐Hansen, A. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.153858 · Cited by 134
The Relative Strength of C-Reactive Protein and Lipid Levels as Determinants of Ischemic Stroke Compared With Coronary Heart Disease in Women
Everett, B. M., Kurth, T., Buring, J. E., & Ridker, P. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.030 · Cited by 130
An update on coronary risk factors
Kannel, W. B., & Wilson, P. W. F. (1995) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30016-5 · Cited by 128
Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study
Lamarche, B., Després, J., Moorjani, S., Cantin, B., Dagenais, G. R., & Lupien, P.-J. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05653-x · Cited by 129
Determinants of severity of coronary artery disease in Australian men and women.
Wang, X.-L., Tam, C., Mccredie, R., & Wilcken, D. (1994) · Circulation · doi:10.1161/01.cir.89.5.1974 · Cited by 143
Physiologic Testosterone Levels in Normal Men Suppress High-Density Lipoprotein Cholesterol Levels
Bagatell, C. J., Knopp, R. H., Vale, W., Rivier, J. E., & Bremner, W. J. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-12-967 · Cited by 129
Efficacy of lipid profiles in prediction of coronary disease
Kannel, W. B., & Wilson, P. W. F. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90288-7 · Cited by 128
Prospective Study of Moderate Alcohol Consumption and Risk of Peripheral Arterial Disease in US Male Physicians
Camargo, C. A., Stampfer, M. J., Glynn, R. J., Gaziano, J. M., Manson, J. E., Goldhaber, S. Z., & Hennekens, C. H. (1997) · Circulation · doi:10.1161/01.cir.95.3.577 · Cited by 126
Self-citation
Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
Rader, D. J., Ikewaki, K., Duverger, N., Schmidt, H., Pritchard, H., Frohlich, J., Clerc, M., Dumon, M. F., Fairwell, T., & Zech, L. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116962 · Cited by 125
Oral Estrogen Replacement Therapy in Postmenopausal Women Selectively Raises Levels and Production Rates of Lipoprotein A-I and Lowers Hepatic Lipase Activity Without Lowering the Fractional Catabolic Rate
Brinton, E. A. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.3.431 · Cited by 125
Consumption of trans fats and estimated effects on coronary heart disease in Iran
Mozaffarian, D., Abdollahi, M., Campos, H., Houshiarrad, A., & Willett, W. C. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602608 · Cited by 124
Self-citation
Regulation of High-Density Lipoprotein Metabolism
Rye, K., & Barter, P. J. (2014) · Circulation Research · doi:10.1161/circresaha.114.300632 · Cited by 128
From High-Density Lipoprotein Cholesterol to Measurements of Function
Sacks, F. M., & Jensen, M. K. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.307025 · Cited by 121
Self-citation
Combined epigallocatechin-3-gallate and resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: a randomized controlled trial
Most, J., Timmers, S., Warnke, I., Jocken, J. W. E., Boekschoten, M. V., de Groot, P., Bendik, I., Schrauwen, P., Goossens, G. H., & Blaak, E. E. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.122937 · Cited by 121
The Impact of a Prospective Survey-Based Workplace Intervention Program on Employee Health, Biologic Stress Markers, and Organizational Productivity
n, I. A., & Arnetz, B. B. (2005) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000167259.03247.1e · Cited by 118
Spreads enriched with plant sterols, either esterified 4,4-dimethylsterols or free 4-desmethylsterols, and plasma total- and LDL-cholesterol concentrations
Sierksma, A., Weststrate, J. A., & Meijer, G. W. (1999) · British Journal Of Nutrition · doi:10.1017/s0007114599001476 · Cited by 117
Loss of abdominal fat and improvement of the cardiovascular risk profile by regular moderate exercise training in patients with NIDDM
Lehmann, R., Vokac, A., Niedermann, K., Agosti, K., & Spinas, G. A. (1995) · Diabetologia · doi:10.1007/bf00401764 · Cited by 123
Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease
Drexel, H., Amann, F. W., Rentsch, K., Neuenschwander, C., Luethy, A., Khan, S. I., & Folláth, F. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91186-8 · Cited by 115
Plasma Concentrations of Interleukin-6 and Abdominal Aortic Diameter Among Subjects Without Aortic Dilatation
Rohde, L. E. P., Arroyo, L. H., Rifai, N., Creager, M. A., Libby, P., Ridker, P. M., & Lee, R. T. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.7.1695 · Cited by 115
High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences
Francis, G. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00181-x · Cited by 114
Polymorphism of the Apolipoprotein E Gene and Early Carotid Atherosclerosis Defined by Ultrasonography in Asymptomatic Adults
Cattin, L., Fisicaro, M., Tonizzo, M., Valenti, M., Danek, G. M., Fonda, M., Col, P. G. D., Casagrande, S., Pincetti, E., Bovenzi, M., et al. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.1.91 · Cited by 114
The Inflamed Liver and Atherosclerosis: A Link Between Histologic Severity of Nonalcoholic Fatty Liver Disease and Increased Cardiovascular Risk
Alkhouri, N., Tamimi, T., Yerian, L. M., López, R., Zein, N. N., & Feldstein, A. E. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-1075-y · Cited by 116
Apolipoprotein A-II Is Inversely Associated With Risk of Future Coronary Artery Disease
Birjmohun, R. S., Dallinga‐Thie, G. M., Kuivenhoven, J. A., Stroes, E. S. G., Otvos, J. D., Wareham, N. J., Luben, R., Kastelein, J. J. P., Khaw, K., & Boekholdt, S. M. (2007) · Circulation · doi:10.1161/circulationaha.107.704031 · Cited by 113
Tibolone: a review
Albertazzi, P., Micco, R. D., & Zanardi, E. (1998) · Maturitas · doi:10.1016/s0378-5122(98)00059-0 · Cited by 113
Epidemiologic aspects of lipid abnormalities
Criqui, M. H., & Golomb, B. A. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00212-5 · Cited by 158
Pharmacology of conjugated equine estrogens: Efficacy, safety and mechanism of action
Bhavnani, B. R., & Stanczyk, F. Z. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.10.011 · Cited by 113
The association of diet and thrombotic risk factors in healthy male vegetarians and meat-eaters
Li, D., Sinclair, A. J., Mann, N. J., Turner, A., Ball, M., Kelly, F. J., Abedin, L., & Wilson, A. (1999) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600817 · Cited by 108
Systemic adverse effects of beta-adrenergic blockers: an evidence-based assessment
Lama, P. J. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01699-9 · Cited by 109
In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport
Pieters, M. N., Schouten, D., & van Berkel, T. J. C. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(94)90069-8 · Cited by 107
Gender‐Specific Regulation of Cardiovascular Function: Estrogen as Key Player
Huang, A., & Kaley, G. (2004) · Microcirculation · doi:10.1080/10739680490266162 · Cited by 108
Associations between serum lipids and indicators of adiposity in men with spinal cord injury
Maki, K. C., BRIONES, E. R., Langbein, W. E., Inman-Felton, A., Nemchausky, B. M., Welch, M., & Burton, J. (1995) · Spinal Cord · doi:10.1038/sc.1995.24 · Cited by 107
Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men
Cremer, P., Nagel, D., Mann, H., Labrot, B., Müller-Berninger, R., Elster, H., & Seidel, D. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06030-3 · Cited by 108
Novel metabolic biomarkers of cardiovascular disease
Jensen, M. K., Bertoia, M. L., Cahill, L. E., Agarwal, I., Rimm, E. B., & Mukamal, K. J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.155 · Cited by 109
The cardiac and haemostatic effects of dietary hempseed
Rodriguez–Leyva, D., & Pierce, G. N. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-32 · Cited by 108
Development of a microfluidic electrochemical biosensor: Prospect for point-of-care cholesterol monitoring
Kaur, G., Tomar, M., & Gupta, V. (2018) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2018.01.144 · Cited by 109
Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia.
Ng, D. S., Leiter, L. A., Vézina, C., Connelly, P. W., & Hegele, R. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116949 · Cited by 107
Androgen and progestagen effects on plasma lipids
Bagatell, C. J., & Bremner, W. J. (1995) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(95)80016-6 · Cited by 107
Insulin-like Growth Factors and Prostate Cancer
Pollak, M. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000796 · Cited by 107
The effects of weight loss by exercise or by dieting on plasma high-density lipoprotein (HDL) levels in men with low, intermediate, and normal-to-high HDL at baseline
Williams, P. T., Stefanick, M. L., Vranizan, K. M., & Wood, P. D. (1994) · Metabolism · doi:10.1016/0026-0495(94)90277-1 · Cited by 106
The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease
Maron, D. J. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01462-4 · Cited by 107
Techno-Stress
Arnetz, B. B. (1996) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-199601000-00017 · Cited by 106
Alcohol's effects on the risk for coronary heart disease.
Mukamal, K. J., & Rimm, E. B. (2001) · PubMed Central · Cited by 104
Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of HDL and apo A-I.
Sigurðsson, G., Gudnason, V. G., Sigurðsson, G., & Humphries, S. E. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.9.1017 · Cited by 103
Non-alcoholic fatty liver disease and cardiovascular risk
Brea, Á., & Puzo, J. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.09.085 · Cited by 109

Authors: Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., & Hennekens, C. H.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Stampfer, Meir J.
Sacks, Frank M.
Willett, Walter C.
Hennekens, Charles H.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1991-08-08
Volume: 325
Issue: 6
Pages: 373-381
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199108083250601
OpenAlex: W2337032743
Cited by: 1,163
References: 56
Citations by year: 2026: 6 · 2025: 5 · 2024: 10 · 2023: 10 · 2022: 7 · 2021: 12 · 2020: 14 · 2019: 12 · 2018: 18 · 2017: 17 · 2016: 24 · 2015: 31 · 2014: 34 · 2013: 33 · 2012: 31
FWCI: 80.75
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (HL-34595, HL 26490, R01HL034595)
National Cancer Institute (R01CA042182, CA 42182)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: myocardial infarction, HDL cholesterol, HDL2, HDL3, apolipoprotein B-100, apolipoprotein A-I, apolipoprotein A-II, TC/HDL-C ratio, cardiovascular risk prediction, total cholesterol, men, Physicians' Health Study, lipoprotein subfractions, risk factors, coronary heart disease prevention, statin therapy
MeSH terms: Adult, Aged, Aged, 80 and over, Apolipoproteins, Apolipoproteins A, Apolipoproteins B, Cholesterol, Humans, Cholesterol, HDL, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks